Search Results - "Vincent, L M"

Modulation of glucose metabolism by the renin-angiotensin-aldosterone system by Favre, Guillaume A, Esnault, Vincent L M, Van Obberghen, Emmanuel

“…The renin-angiotensin-aldosterone system (RAAS) is an enzymatic cascade functioning in a paracrine and autocrine fashion. In animals and humans, RAAS intrinsic…”
Get more information

Extracellular fluid volume: A suitable indexation variable to assess impact of bariatric surgery on glomerular filtration rate in patients with chronic kidney disease by Grangeon-Chapon, Caroline, Laurain, Audrey, Esnault, Vincent L M, Cruzel, Coralie, Iannelli, Antonio, Favre, Guillaume A

“…Bariatric surgery (BS) might be a nephroprotective treatment in obese patients with chronic kidney disease (CKD), and the non-linear relation between body…”
Get full text

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy by Teisseyre, Maxime, Cremoni, Marion, Boyer-Suavet, Sonia, Ruetsch, Caroline, Graça, Daisy, Esnault, Vincent L M, Brglez, Vesna, Seitz-Polski, Barbara

“…Primary membranous nephropathy (pMN) is an auto-immune disease characterized by auto-antibodies targeting podocyte antigens resulting in activation of…”
Get full text

Immune checkpoint inhibitors-induced nephropathy: a French national survey by Gérard, Alexandre O., Andreani, Marine, Fresse, Audrey, Parassol, Nadège, Muzzone, Marine, Pinel, Sylvine, Bourneau-Martin, Delphine, Borchiellini, Delphine, Rocher, Fanny, Esnault, Vincent L. M., Drici, Milou-Daniel

“…Immune checkpoint inhibitors (ICIs), aiming to foster cancer-targeted immune response, proved to be effective in several advanced malignancies at the price of…”
Get full text

Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth? by Gérard, Alexandre O, Laurain, Audrey, Favre, Guillaume, Drici, Milou-Daniel, Esnault, Vincent L M

Get full text

Cost‐effectiveness of screening for HLA‐A31:01 prior to initiation of carbamazepine in epilepsy by Plumpton, Catrin O., Yip, Vincent L. M., Alfirevic, Ana, Marson, Anthony G., Pirmohamed, Munir, Hughes, Dyfrig A.

“…Summary Objective Carbamazepine causes severe cutaneous adverse drug reactions that may be predicted by the presence of the HLA‐A*31:01 allele in northern…”
Get full text

Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from Epoxide Metabolites of Carbamazepine in Patients by Yip, Vincent L. M, Meng, Xiaoli, Maggs, James L, Jenkins, Rosalind E, Marlot, Philippe T, Marson, Anthony G, Park, B. Kevin, Pirmohamed, Munir

“…Carbamazepine (CBZ) is an effective antiepileptic drug that has been associated with hypersensitivity reactions. The pathogenesis of those reactions is…”
Get full text

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients by Cremoni, Marion, Allouche, Jonathan, Graça, Daisy, Zorzi, Kevin, Fernandez, Céline, Teisseyre, Maxime, Benzaken, Sylvia, Ruetsch-Chelli, Caroline, Esnault, Vincent L. M., Dellamonica, Jean, Carles, Michel, Barrière, Jérôme, Ticchioni, Michel, Brglez, Vesna, Seitz-Polski, Barbara

“…The SARS-CoV-2 infection has spread rapidly around the world causing millions of deaths. Several treatments can reduce mortality and hospitalization. However,…”
Get full text

New Strategies for Volume Control in Patients with Diabetes Mellitus, a Narrative Review by Gérard, Alexandre O, Laurain, Audrey, Sicard, Antoine, Merino, Diane, Pathak, Atul, Drici, Milou-Daniel, Favre, Guillaume, Esnault, Vincent L. M

“…Sodium is reabsorbed all along the renal tubules. The positive impacts of sodium-glucose cotransporter-2 inhibitors (SGLT2i), angiotensin receptor neprilysin…”
Get full text

Quality of life in children suffering from headaches: a systematic literature review by Ombashi, S., Tsangaris, E., Heeres, A. G., van Roey, V., Neuteboom, R. F., van Veelen-Vincent, M. L. C., Jansson, K., Mathijssen, I. M. J., Klassen, A. F., Versnel, S. L.

“…Background Headaches are the most common complaints among pediatric populations. Determining the cause and appropriate treatment for headaches may be…”
Get full text

Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients by Bleumin, Dina, Cohen, Matan J, Moranne, Olivier, Esnault, Vincent L.M, Benenson, Shmuel, Paltiel, Ora, Tzukert, Keren, Mor-Yosef Levi, Irit, Ben-Dov, Iddo Z, Levi, Ronen, Bloch, Aharon, Haviv, Yosef S

“…Summary Background Hemodialysis (HD) units have become a source of resistant bacteria. One of the most alarming developments is the emergence of…”
Get full text

Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients by Gérard, Alexandre, Doyen, Jerome, Cremoni, Marion, Bailly, Laurent, Zorzi, Kevin, Ruetsch-Chelli, Caroline, Brglez, Vesna, Picard-Gauci, Alexandra, Troin, Laura, Esnault, Vincent L.M., Passeron, Thierry, Montaudié, Henri, Seitz-Polski, Barbara

“…BackgroundDespite significant progress with antiprogrammed cell death protein 1 (PD-1) therapy, a substantial fraction of metastatic melanoma patients show…”
Get full text

Submucosal purse-string suture as a treatment of leakage around the indwelling voice prosthesis by Jacobs, Kristien, Delaere, Pierre R., Poorten, Vincent L. M. Vander

“…Background. Leakage around the indwelling voice prosthesis is an annoying complication of tracheoesophageal speech. Methods. Twenty patients, who experienced…”
Get full text

Cardiovascular Events with Finerenone in CKD and Diabetes by Gérard, Alexander O, Laurain, Audrey, Esnault, Vincent L M

Get full text

Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy by Seitz-Polski, Barbara, Debiec, Hanna, Rousseau, Alexandra, Dahan, Karine, Zaghrini, Christelle, Payré, Christine, Esnault, Vincent L M, Lambeau, Gérard, Ronco, Pierre

“…The phospholipase A2 receptor (PLA2R1) is the major autoantigen in primary membranous nephropathy. Several PLA2R1 epitopes have been characterized, and a…”
Get full text

Adhesion of mammalian cells to polymer surfaces: from physical chemistry of surfaces to selective adhesion on defined patterns by Dewez, J.-L., Lhoest, J.-B., Detrait, E., Berger, V., Dupont-Gillain, C.C., Vincent, L.-M., Schneider, Y.-J., Bertrand, P., Rouxhet, P.G.

“…The study of the adsorption of type I collagen from a solution containing Pluronic ® F68 has shown that the latter prevents collagen adsorption on polystyrene…”
Get full text

Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy by Seitz-Polski, Barbara, Dolla, Guillaume, Payré, Christine, Girard, Christophe A, Polidori, Joel, Zorzi, Kevin, Birgy-Barelli, Eléonore, Jullien, Perrine, Courivaud, Cécile, Krummel, Thierry, Benzaken, Sylvia, Bernard, Ghislaine, Burtey, Stéphane, Mariat, Christophe, Esnault, Vincent L M, Lambeau, Gérard

“…The phospholipase A2 receptor (PLA2R1) is the major autoantigen in idiopathic membranous nephropathy. However, the value of anti-PLA2R1 antibody titers in…”
Get full text

High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy by Seitz-Polski, Barbara, Dahan, Karine, Debiec, Hanna, Rousseau, Alexandra, Andreani, Marine, Zaghrini, Christelle, Ticchioni, Michel, Rosenthal, Alessandra, Benzaken, Sylvia, Bernard, Ghislaine, Lambeau, Gérard, Ronco, Pierre, Esnault, Vincent L M

“…Different rituximab protocols are used to treat membranous nephropathy. We compared two rituximab protocols in patients with membranous nephropathy…”
Get full text

Empagliflozin in Heart Failure by Gérard, Alexandre O, Favre, Guillaume, Esnault, Vincent L M

Get full text

Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database by Gérard, Alexandre O., Laurain, Audrey, Fresse, Audrey, Parassol, Nadège, Muzzone, Marine, Rocher, Fanny, Esnault, Vincent L.M., Drici, Milou‐Daniel

“…Remdesivir is approved for emergency use by the US Food and Drug Administration (FDA) and authorized conditionally by the European Medicines Agency (EMA) for…”
Get full text